Bio-Solutions Corp. (BISU) 0.0059 $BISU
BISU Now OTCQB Current Reporting
ACCESSWIRE - Mon Jul 21, 6:09AM CDT
SAN ANTONIO, TEXAS / ACCESSWIRE / July 21, 2014 / Bio-Solutions Corp. (OTCQB: BISU), a fast growing dietary supplement manufacturer, announced today with the filing of its 10Q, Bio-Solutions Corp. (the "Company"
has regained the status as fully reporting. Company Treasurer Rick Basse remarked, "We are very excited to have completed this daunting task with the assistance of our new auditors. Now as a team, BISU will forge forward in promotion and distribution of its lead product Type 2 Defense."
Bio Solutions Corp. Appoints Thomas E. Metzger, PhD as President
ACCESSWIRE - Wed Feb 26, 7:31AM CST
SAN ANTONIO, TEXAS / February 25, 2014 / ACCESSWIRE / Bio-Solutions Corp (BISU.OTC) has appointed Thomas E. Metzger, PhD as President of the company. "Thomas has been very strategic in his role as COO and as a Board member for us", states William Gallagher, Chairman and CEO "Thomas will serve a duel role as President and COO for our continued growth".
Bio-Solutions Announces Agreement with New Northwest Arkansas Co-Packer to Produce and Distribute Type 2 Defense Drink Mix
ACCESSWIRE - Mon Feb 10, 8:38AM CST
New co-packer based out of Northwest Arkansas, the home of Walmart and Sam's Club Corporate Headquarters
Bio-Solutions Completes First Phase of New Infomercial for Type2Defense
Marketwire - Tue Sep 10, 7:02AM CDT
Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) today announced it completed the first phase of its infomercial with GVP Digital. The shooting was done on location at a multi-million dollar penthouse, located in the Tribeca section of Manhattan.
Bio-Solutions Corp. Expanding in Booming Diabetes Market
PR Newswire - Thu Aug 29, 8:05AM CDT
On Wednesday, Bio-Solutions Corp. (OTCQB: BISU) announced their Direct Response Infomercial and Marketing Campaign for its flagship product, Type2Defense. Over 30 million people suffer from Type 2 diabetes in the United States, according to seeking alpha. Additionally, it's forecasted that nearly 30 percent of the U.S.'s population will have diabetes by 2050, with most of that percentage facing Type 2.
Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
PR Newswire - Wed Aug 28, 8:05AM CDT
FinancialNewsMedia.com issues news updates for today's leading healthcare companies: Bio-Solutions Corp. (OTCQB: BISU), Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), MannKind Corporation (NASDAQ: MNKD), Amgen (NASDAQ: AMGN) and Accuray Incorporated (NASDAQ: ARAY).
Bio-Solutions Corp. Announces National Direct Response Marketing Campaign for Type2Defense(TM)
PR Newswire - Wed Aug 28, 6:30AM CDT
Bio-Solutions Corp. (OTCQB: BISU) today announces a major step in their company's expansion process across the USA and commitment to growth across America; as management celebrates the national roll-out of a Direct Response Infomercial and Marketing Campaign for it's flagship product Type2Defense(TM).
Bio-Solutions Corporation Announces Campaign on Lockerdome.com to Help Raise Money for the Benefit of Juvenile Diabetes
PR Newswire - Tue Aug 27, 6:30AM CDT
Bio-Solutions Corporation (OTCQB: BISU) is pleased to announce that we have initiated a campaign on Lockerdome.com to help raise money for the benefit of Juvenile Diabetes. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes. Monthly traffic to Lockerdome.com is in excess of 14 million visitors per month and Bio-Solutions is confident that it can reach athletes who have diabetes through Lockerdome.com and help them reach their training potential by using the company's product, Type 2 Defense.
OTC Daily Alert Stock Watch - Bio-Solutions Corp (OTCBB:BISU)
WorldStockWire - Tue Aug 13, 6:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders
Marketwire - Tue Jul 09, 10:01AM CDT
Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) www.BioSolutionsCorp.com - In a joint effort to accommodate the growing demand for the company's product, Bio-Solutions Corp. has launched its official online retail store at www.Type2Defense.com while maintaining its distribution agreement with the Amazon store Healthy Provisions.
Bio-Solutions Corporation Comments on Unusual Trading Activity
Marketwire - Tue Jul 09, 8:03AM CDT
Bio-Solutions Corporation (OTCQB: BISU)(PINKSHEETS: BISU) is pleased to comment on the unusual trading activity in the company's common stock listed on the OTC market in the United States. Yesterday, the company did receive several calls from shareholders who were concerned about the spike in volume and the slide in price of our shares. We are happy to report that the company and insiders are not sellers of stock at these prices. Furthermore, there are no plans for the company to raise money at these levels. It is reasonable to assume that some shareholders who bought stock under $0.01 might be sellers at these prices.
Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store
Marketwire Canada - Mon Jul 08, 6:30AM CDT
Bio-Solutions Corp. (OTCQB:BISU)(PINKSHEETS:BISU) (www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.
Bio-Solutions Corporation Completes Initial Production of Diabetic Product, Type2 Defense
Marketwire - Thu Jun 27, 7:45AM CDT
Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is pleased to announce that the company has completed its initial order of the diabetic product Type2 Defense with Nutricap Labs located in Farmingdale, New York. The successful completion of the initial production order is an important milestone for Bio-Solutions Corporation. The company is now positioned to distribute final product samples to the different groups that are presently considering endorsing the Type2 Defense product and begin set-up of proper distribution channels for the product.
Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE
Marketwire - Mon May 20, 12:02PM CDT
Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant.
Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp.
Marketwire - Mon May 20, 8:02AM CDT
(OTCQB: BISU) (PINKSHEETS: BISU) - Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal proposed by Bio-Solutions Corporation for Type-2 Defense, a preventative supplement for people who are diabetic or even pre-diabetic. This product helps regulate blood sugar levels, especially for people who are insulin-resistant.
BISU Now OTCQB Current Reporting
ACCESSWIRE - Mon Jul 21, 6:09AM CDT
SAN ANTONIO, TEXAS / ACCESSWIRE / July 21, 2014 / Bio-Solutions Corp. (OTCQB: BISU), a fast growing dietary supplement manufacturer, announced today with the filing of its 10Q, Bio-Solutions Corp. (the "Company"
has regained the status as fully reporting. Company Treasurer Rick Basse remarked, "We are very excited to have completed this daunting task with the assistance of our new auditors. Now as a team, BISU will forge forward in promotion and distribution of its lead product Type 2 Defense." Bio Solutions Corp. Appoints Thomas E. Metzger, PhD as President
ACCESSWIRE - Wed Feb 26, 7:31AM CST
SAN ANTONIO, TEXAS / February 25, 2014 / ACCESSWIRE / Bio-Solutions Corp (BISU.OTC) has appointed Thomas E. Metzger, PhD as President of the company. "Thomas has been very strategic in his role as COO and as a Board member for us", states William Gallagher, Chairman and CEO "Thomas will serve a duel role as President and COO for our continued growth".
Bio-Solutions Announces Agreement with New Northwest Arkansas Co-Packer to Produce and Distribute Type 2 Defense Drink Mix
ACCESSWIRE - Mon Feb 10, 8:38AM CST
New co-packer based out of Northwest Arkansas, the home of Walmart and Sam's Club Corporate Headquarters
Bio-Solutions Completes First Phase of New Infomercial for Type2Defense
Marketwire - Tue Sep 10, 7:02AM CDT
Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) today announced it completed the first phase of its infomercial with GVP Digital. The shooting was done on location at a multi-million dollar penthouse, located in the Tribeca section of Manhattan.
Bio-Solutions Corp. Expanding in Booming Diabetes Market
PR Newswire - Thu Aug 29, 8:05AM CDT
On Wednesday, Bio-Solutions Corp. (OTCQB: BISU) announced their Direct Response Infomercial and Marketing Campaign for its flagship product, Type2Defense. Over 30 million people suffer from Type 2 diabetes in the United States, according to seeking alpha. Additionally, it's forecasted that nearly 30 percent of the U.S.'s population will have diabetes by 2050, with most of that percentage facing Type 2.
Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
PR Newswire - Wed Aug 28, 8:05AM CDT
FinancialNewsMedia.com issues news updates for today's leading healthcare companies: Bio-Solutions Corp. (OTCQB: BISU), Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), MannKind Corporation (NASDAQ: MNKD), Amgen (NASDAQ: AMGN) and Accuray Incorporated (NASDAQ: ARAY).
Bio-Solutions Corp. Announces National Direct Response Marketing Campaign for Type2Defense(TM)
PR Newswire - Wed Aug 28, 6:30AM CDT
Bio-Solutions Corp. (OTCQB: BISU) today announces a major step in their company's expansion process across the USA and commitment to growth across America; as management celebrates the national roll-out of a Direct Response Infomercial and Marketing Campaign for it's flagship product Type2Defense(TM).
Bio-Solutions Corporation Announces Campaign on Lockerdome.com to Help Raise Money for the Benefit of Juvenile Diabetes
PR Newswire - Tue Aug 27, 6:30AM CDT
Bio-Solutions Corporation (OTCQB: BISU) is pleased to announce that we have initiated a campaign on Lockerdome.com to help raise money for the benefit of Juvenile Diabetes. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes. Monthly traffic to Lockerdome.com is in excess of 14 million visitors per month and Bio-Solutions is confident that it can reach athletes who have diabetes through Lockerdome.com and help them reach their training potential by using the company's product, Type 2 Defense.
OTC Daily Alert Stock Watch - Bio-Solutions Corp (OTCBB:BISU)
WorldStockWire - Tue Aug 13, 6:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders
Marketwire - Tue Jul 09, 10:01AM CDT
Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) www.BioSolutionsCorp.com - In a joint effort to accommodate the growing demand for the company's product, Bio-Solutions Corp. has launched its official online retail store at www.Type2Defense.com while maintaining its distribution agreement with the Amazon store Healthy Provisions.
Bio-Solutions Corporation Comments on Unusual Trading Activity
Marketwire - Tue Jul 09, 8:03AM CDT
Bio-Solutions Corporation (OTCQB: BISU)(PINKSHEETS: BISU) is pleased to comment on the unusual trading activity in the company's common stock listed on the OTC market in the United States. Yesterday, the company did receive several calls from shareholders who were concerned about the spike in volume and the slide in price of our shares. We are happy to report that the company and insiders are not sellers of stock at these prices. Furthermore, there are no plans for the company to raise money at these levels. It is reasonable to assume that some shareholders who bought stock under $0.01 might be sellers at these prices.
Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store
Marketwire Canada - Mon Jul 08, 6:30AM CDT
Bio-Solutions Corp. (OTCQB:BISU)(PINKSHEETS:BISU) (www.BioSolutionsCorp.com) has done it! In this first step to the company's expansion process across the USA and commitment to growth across America, management celebrates the national roll-out of its flagship product Type2Defense(TM) on the Healthy Provisions Amazon store via its partnership agreement with Kee Holdings Inc. The product can be purchased by following the online ordering link on the company website at: www.biosolutionscorp.com.
Bio-Solutions Corporation Completes Initial Production of Diabetic Product, Type2 Defense
Marketwire - Thu Jun 27, 7:45AM CDT
Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is pleased to announce that the company has completed its initial order of the diabetic product Type2 Defense with Nutricap Labs located in Farmingdale, New York. The successful completion of the initial production order is an important milestone for Bio-Solutions Corporation. The company is now positioned to distribute final product samples to the different groups that are presently considering endorsing the Type2 Defense product and begin set-up of proper distribution channels for the product.
Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE
Marketwire - Mon May 20, 12:02PM CDT
Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant.
Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp.
Marketwire - Mon May 20, 8:02AM CDT
(OTCQB: BISU) (PINKSHEETS: BISU) - Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal proposed by Bio-Solutions Corporation for Type-2 Defense, a preventative supplement for people who are diabetic or even pre-diabetic. This product helps regulate blood sugar levels, especially for people who are insulin-resistant.
